ArticlePostepy dermatologii i alergologii2026
Management of paediatric anaphylaxis: evaluation of clinical practice according to the 2024 Polish Paediatric Society guidelines.
Article in Postepy dermatologii i alergologii, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Anaphylaxis is a severe, rapidly progressing allergic reaction that can be life-threatening. It may involve the skin and mucous membranes, as well as the respiratory, cardiovascular, or gastrointestinal systems. In children, it most often occurs at home, in kindergarten, or at school, with food being the predominant trigger. Immediate intramuscular adrenaline is the treatment of choice. Aim: To evaluate clinical practice in managing paediatric anaphylaxis according to the 2024 Polish Paediatric Society recommendations. Material and methods: A retrospective analysis was conducted on medical records of 615 children aged 6 months-17 years hospitalized in the Allergology and Pulmonology Department of the Institute for Tuberculosis and Lung Diseases in Rabka-Zdroj in 2020-2023 for food-induced anaphylaxis (ICD-10 T78.0). Reactions were classified according to the Błażowski Results: Of 615 reactions, 260 met inclusion criteria. SAR occurred in 8%, grade I anaphylaxis in 5.4%, grade II in 48.5%, grade III in 35.4%, and grade IV in 2.7%. Antihistamines were used in 57.3% of cases, corticosteroids in 63.8%, and adrenaline in 17.7%. Adrenaline use was most frequent in hospital settings, lower in prehospital care, and rare among caregivers. Some children received no treatment despite significant symptoms. Conclusions: Adrenaline is underused in paediatric anaphylaxis, particularly outside hospitals. Improved education for caregivers and healthcare providers is essential to ensure timely, guideline-based management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.